Kiora Pharmaceuticals (KPRX) Return on Sales [ROS] (2016 - 2026)
Kiora Pharmaceuticals (KPRX) recorded Return on Sales [ROS] of -55210.80% in Q1 2025, down 55293.44 percentage points from 82.64% a year earlier and down 55238.95 percentage points from the prior quarter.
Powered by 
Analysis
Kiora Pharmaceuticals (KPRX) Return on Sales [ROS] (2016 - 2026) Analysis & Trends
For FY2024, Kiora Pharmaceuticals reported Return on Sales [ROS] of 28.15%.
- Annual Return on Sales [ROS] has a five-year change of +288.80 percentage points (FY2019 to FY2024).
- Across earlier years, Return on Sales [ROS] came in at -56960.51% in FY2020 (-56699.86 pp).
- The Q1 2025 figure is the lowest quarterly Return on Sales [ROS] since Q3 2023.
- On a year-over-year basis, Return on Sales [ROS] rose in three of the last four quarters, with an average year-over-year change of +54853.48 percentage points.
- Per Business Quant, the preceding three quarters came in at 28.15% (Q4 2024), 30.94% (Q3 2024) and -12724.44% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Kiora Pharmaceuticals | 8.53 Mn | -58.79 Mn | - | -1,513.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,513.88% |
| Mar 31, 2026 | -1,801.52% |
| Mar 31, 2025 | -55,210.80% |
| Dec 31, 2024 | 28.15% |
| Sep 30, 2024 | 30.94% |
| Jun 30, 2024 | -12,724.44% |
| Mar 31, 2024 | 82.64% |
| Sep 30, 2023 | -166,686.74% |
| Jun 30, 2023 | -119,671.49% |
| Mar 31, 2023 | -114,404.17% |
| Sep 30, 2022 | -47,106.41% |
| Jun 30, 2022 | -194,183.35% |
| Mar 31, 2022 | -1,644,904.15% |
| Sep 30, 2021 | -1,171,849.03% |
| Dec 31, 2020 | -9,698.80% |
| Sep 30, 2019 | -285.57% |
| Jun 30, 2019 | -233.87% |
| Mar 31, 2019 | 30.85% |
| Sep 30, 2018 | -1,010.45% |
| Jun 30, 2018 | -1,156.27% |
API Access
Kiora Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "KPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();